1. Behtash N, Mousavi A, Tehranian A, Khanafshar N, Hanjani P. Embryonal rhabdomyosarcoma of the uterine cervix: case report and review of the literature. Gynecol Oncol. 2003. 91:452–455.
2. Gordon AN, Montag TW. Sarcoma botryoides of the cervix: excision followed by adjuvant chemotherapy for preservation of reproductive function. Gynecol Oncol. 1990. 36:119–124.
3. Bell J, Averette H, Davis J, Toledano S. Genital rhabdomyosarcoma: current management and review of the literature. Obstet Gynecol Surv. 1986. 41:257–263.
4. Atlante M, Dionisi B, Cioni M, Di Ruzza D, Sedati P, Mariani L. Sarcoma botryoides of the uterine cervix in a young woman: a case report. Eur J Gynaecol Oncol. 2000. 21:504–506.
5. Gruessner SE, Omwandho CO, Dreyer T, Blutters-Sawatzki R, Reiter A, Tinneberg HR, et al. Management of stage I cervical sarcoma botryoides in childhood and adolescence. Eur J Pediatr. 2004. 163:452–456.
6. Villella JA, Bogner PN, Jani-Sait SN, Block AM, Lele S. Rhabdomyosarcoma of the cervix in sisters with review of the literature. Gynecol Oncol. 2005. 99:742–748.
7. Daya DA, Scully RE. Sarcoma botryoides of the uterine cervix in young women: a clinicopathological study of 13 cases. Gynecol Oncol. 1988. 29:290–304.
8. Palazzo JP, Gibas Z, Dunton CJ, Talerman A. Cytogenetic study of botryoid rhabdomyosarcoma of the uterine cervix. Virchows Arch A Pathol Anat Histopathol. 1993. 422:87–91.
9. Zanetta G, Rota SM, Lissoni A, Chiari S, Bratina G, Mangioni C. Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females. Br J Cancer. 1999. 80:403–406.
10. Potzsch C, Voigtlander T, Lubbert M. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies. J Cancer Res Clin Oncol. 2002. 128:456–460.